Size-Controlled Preparation and Behavior Study of Phospholipid–Calcium Carbonate Hybrid Nanoparticles
Authors Wang C, Chen S, Bao L, Liu X, Hu F, Yuan H
Received 3 November 2019
Accepted for publication 7 May 2020
Published 9 June 2020 Volume 2020:15 Pages 4049—4062
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Linlin Sun
Cheng Wang, Shaoqing Chen, Lu Bao, Xuerong Liu, Fuqiang Hu, Hong Yuan
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, People’s Republic of China
Correspondence: Hong Yuan Email firstname.lastname@example.org
Background: Calcium carbonate (CC) nanoparticles have broad biomedical utilizations, owing to their multiple intrinsic merits. However, bare CC nanoparticles do not allow for the development of multifunctional devices suitable for advanced drug delivery in cancer therapy.
Methods: Phospholipid-modified phospholipid–CC hybrid nanoparticles were prepared in our study using a combination of vapor-diffusion and solvent-diffusion methods to offer optimized pharmaceutical capabilities.
Results: Considering that particle size is a critical parameter that plays an important role in both in vitro and in vivo behaviors of nanoparticles, we here for the first time a present detailed protocol for the size-controlled preparation of hybrid nanoparticles, as well as analysis of the in vitro/in vivo behaviors of differently sized hybrid nanoparticles.
Conclusion: Our results might significantly advance the application of this promising material in more varied fields.
Keywords: calcium carbonate, phospholipid, hybrid nanoparticles
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]